Gyre Therapeutics Releases Q1 2026 Financial Results

[ad_1] AlphaStreet Newsdesk powered by AlphaStreet Intelligence GYRE|EPS -$0.10|Rev $22.5M|Net Loss $9.9M Gyre Therapeutics, Inc. (GYRE) reported an adjusted loss of $0.10 per share for the first quarter of 2026, as the pharmaceutical company continues developing its pipeline of anti-inflammatory…

Separatists hold many Malian soldiers captive

Dozens of weary Malian soldiers sat in rows under armed guard as separatist fighters filmed them in northern Mali following last month’s coordinated assaults across the country. Many of the soldiers were captured after the military position in Kidal was…